Loading...

PR Information Data

130 개 4 페이지
번호 컨텐츠
85 IVRA draws attention to presenting a new medical paradigm to overcome COVID-19 2024-02-21   53 (주)아디포랩스
84 COVID-19 new treatment method ‘hyperthermia treatment device’… Research begins in earnest with launch of IVRA 2024-02-21   57 (주)아디포랩스
83 Establishment of IVRA with medical staff from 30 countries, “preparation of coronavirus treatment measures” 2024-02-21   59 (주)아디포랩스
82 International conference ‘IVRA’ held to share hope in medical care to overcome COVID-19 2024-02-21   57 (주)아디포랩스
81 Overcoming the COVID-19 pandemic, we host a stage for sharing medical care 2024-02-21   54 (주)아디포랩스
80 AdipoLABs’ ‘practice of love that transcends borders 2024-02-16   53 (주)아디포랩스
79 AdipoLABs, selected as ‘First in Class’ hyperthermia cancer treatment device 2024-02-16   67 (주)아디포랩스
78 Research on cancer immunotherapy effects of high-frequency hyperthermia cancer treatment device ‘REMISSION 1℃’ begins in earnest 2024-02-16   57 (주)아디포랩스
77 ’'High-frequency heat treatment' that burns away cancer and even 'amplifies' immunity" 2024-02-16   44 (주)아디포랩스
76 AdipoLABs, high-frequency hyperthermia cancer treatment device with a REMISSION 1℃, receives European certification and Malaysian MDA approval 2024-02-16   53 (주)아디포랩스
75 High-frequency hyperthermia cancer treatment device ‘REMISSION 1℃’ opens export path to Malaysia 2024-02-15   47 (주)아디포랩스
74 “There are trials, but there are no failures” AdipoLABs’ CE success story 2024-02-15   45 (주)아디포랩스
73 High-frequency hyperthermia device REMISSION 1℃ receives European CE certification, attracting attention from Malaysian medical community 2024-02-15   40 (주)아디포랩스
72 AdipoLABs’ high-frequency device ‘REMISSION 1℃’ is being exported to Europe 2024-02-15   60 (주)아디포랩스
71 AdipoLABs, "we will definitely prove 'thermotherapy' in cancer and COVID-19" HOT 2020-05-28   3157 (주)아디포랩스